Cutaneous Oncology News

Verrica Pharmaceuticals Inc. has reported lesion clearance data from part one of an ongoing phase 2 study of VP-315 for the treatment of basal cell carcinoma, according to a press release from Verrica’s licensing partner, Lytix Biopharma.

The dawning of genomic testing has shown that Spitz neoplasm cases occur at equal rates among children and adults, which should prompt clinicians to diagnose Spitz neoplasms more confidently among older patients, according to a study.

Neoadjuvant talimogene laherparepvec conferred durable benefits for patients with advanced resectable melanoma, according to study results published in JAMA Oncology.

The strongest predictor of lentigo maligna melanoma progression is histologic margin status, and patients with margins less than 3 mm should consider re-excision, according to a study.

Early detection continues to fail as an intervention for melanoma among patients with skin of color, prompting the need for other approaches, according to a study.

Artificial intelligence was highly successful in diagnosing skin disease among patients with Fitzpatrick skin types IV to VI, according to a study.

Organ transplant recipients diagnosed with cutaneous squamous cell carcinoma are more likely to experience recurrence, metastasis and death from this cancer compared with non-organ transplant recipients, according to a study.

The European Medicines Agency’s Committee for Medicinal Products for Human Use has recommended the approval of Opdivo for melanoma treatment in patients aged 12 years and older, according to a Bristol Myers Squibb press release.

Google searches about sunscreen use for patients with skin of color have quadrupled since 2006, giving dermatologists a prime opportunity to increase sunscreen education in this population, according to a study.

Patient satisfaction after Mohs micrographic surgery is affected by numerous factors that may change over time, according to a study.